Drug profile · INN
tirabrutinib hydrochloride
VELEXBRU INITIAL APPROVAL
tirabrutinib hydrochloride (VELEXBRU INITIAL APPROVAL) is an FDA-listed pharmaceutical active ingredient.
PMDA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — tirabrutinib hydrochloride
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.78
Quick answer
tirabrutinib hydrochloride (VELEXBRU INITIAL APPROVAL) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN tirabrutinib hydrochloride
Brand VELEXBRU INITIAL APPROVAL
Approval history
| Authority | Status | Date |
|---|---|---|
| PMDA | approved | — |
Frequently asked questions
What is tirabrutinib hydrochloride?
tirabrutinib hydrochloride (VELEXBRU INITIAL APPROVAL) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for tirabrutinib hydrochloride?
VELEXBRU INITIAL APPROVAL is a marketed brand name for tirabrutinib hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.